Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

S&P, Dow rise as weekly jobless claims dip; Nasdaq retreats

Published 2020-12-23, 07:09 a/m
© Reuters. FILE PHOTO: Raindrops hang on a sign for Wall Street outside the New York Stock Exchange in New York
US500
-
DJI
-
MSFT
-
AMZN
-
PFE
-
RSG
-
IXIC
-
AAL
-

By Devik Jain and Ambar Warrick

(Reuters) - The S&P 500 and the Dow rose on Wednesday as jobless claims unexpectedly fell last week, while the Nasdaq retreated from a record high close on losses in heavyweight technology stocks.

The markets also appeared to have shrugged off a threat from President Donald Trump to not sign an $892 billion coronavirus relief bill, saying it should be amended to increase the amount in the stimulus checks.

While the Labor Department's data showed initial claims for state unemployment benefits fell last week, they remained at elevated levels due to restrictions to curb the spread of new COVID-19 infections.

Meanwhile, a separate report showed consumer spending fell last month for the first time since April, due to weakness in the job market.

"There's this conflict between the immediate term, where economic conditions are likely to get worse, but longer term, things should improve quite a bit. The stimulus also helps bridge that gap," said Chuck Lieberman, chief investment officer of Advisor Capital Management in New Jersey.

At 9:41 a.m. ET, the Dow Jones Industrial Average was up 193.58 points, or 0.64%, at 30,209.09, the S&P 500 was up 16.83 points, or 0.46%, at 3,704.09. The Nasdaq Composite was down 7.66 points, or 0.06%, at 12,800.26.

Nine of the 11 major S&P sectors were higher, with energy stocks rising the most.

Microsoft (NASDAQ:MSFT), Paypal and Amazon.com (NASDAQ:AMZN) were among the biggest drags on the Nasdaq.

Concerns over a new variant of the coronavirus and weakening economic data have weighed on Wall Street in recent sessions. But technology stocks have consistently outperformed their peers, thanks to the sector's perceived resilience to virus-related disruptions.

Easy monetary policy, increased liquidity in the market and positive COVID-19 vaccine data has set the main indexes for strong annual gains, despite a rough start to the year.

Drugmaker Pfizer Inc (NYSE:PFE) rose 1.7% after a deal to supply the United States with 100 million additional doses of its COVID-19 vaccine by July.

Merck & Co Inc added 0.8% following its own COVID-19 treatment agreement with the United States.

Supernus Pharmaceuticals Inc jumped 15.8% after its experimental drug for attention deficit hyperactivity disorder met the main goal of a late-stage study in adults.

Electric-truck maker Nikola Corp fell 10.1% after it called off a deal to develop electric garbage trucks with recycling and waste disposal firm Republic Services Inc (NYSE:RSG).

American Airlines (NASDAQ:AAL) Group and United Airlines Holdings rose 2.2% and 3.2%, respectively, as they outlined plans to bring back furloughed employees this month. The airline industry is set to receive about $15 billion in government support.

Advancing issues outnumbered decliners by a 3.83-to-1 ratio on the NYSE, and by a 2.19-to-1 ratio on the Nasdaq.

© Reuters. FILE PHOTO: Raindrops hang on a sign for Wall Street outside the New York Stock Exchange in New York

The S&P index recorded 27 new 52-week highs and no new low, while the Nasdaq recorded 177 new highs and no new low.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.